Only 17.29 to go on GNID PPS Prediction from GNID CEO Study. OOPS 17.345.
GNID CEO Lorraine got this...
RX Safes Releases Preliminary Research Report on Company
Analyst Highlights Company Products and Markets With an "Outperform" Rating
HENDERSON, NV--(Marketwired - Dec 22, 2015) - Rx Safes, Inc. (OTCQB: RXSF), the developer of patented autonomous fingerprint healthcare security products announced today that it has released the company's first commissioned research report that highlights the company's products, analyzes the specific healthcare sub-markets its products are designed for, and has an outperform rating with a 2016 targeted share price of $17.41.
The Problem: FAILURE by a CEO in PENNYLAND, is not only an Acceptable Practice, it REWARDS a CEO... It's much EASIER for CEO to make money selling Company shares, than Build a Company.